Maglangit, Alma May G.
HRN: 21-89-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
CIPROFLOXACIN 500MG (TAB)
09/15/2022
09/22/2022
ORAL
500mg
BID
AGE With Mod Dhn; Tc UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes